Our finding of LLT1 over expression in prostate cancer could lead to novel therapeutic strategies to eliminate prostate cancer by blocking the inhibitory signal through LLT1-NKRP1A interaction. The gene discussed is KLRB1; the disease is prostate carcinoma.